Given these considerations, we hypothesised that high plasma levels of MMP-9 and its inhibitor TIMP-1 as well as NGAL can be related to chronic microvascular complications in individuals with type 1 diabetes, such as diabetes nephropathy and diabetes neuropathy. Here, MMP9 is linked to diabetic kidney disease.